Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Skycorp PN Stock Momentum Behavior 076 20260422 Prologis Inc PLD YTD Outperformance Versus Finance Sector Peers and NearTerm Outlook Market Recap Tech outpaces consumer as markets dip modestly Preformed PLPC Stock Key Catalysts Ahead Smart Money Active 20260422 NewtekOne NEWT Stock PreEarnings Sideways 20260420 How Astrotech ASTC pricing changes flow through to earnings ASTC Q1 2024 Astrotech Swings to 179 Loss on Minimal Revenue HFWA Heritage delivers modest Q1 2026 EPS beat shares edge slightly higher after earnings release What InnSuites IHT is doing that smarter investors notice Ticks Lower 20260506 TREX Trex Company beats Q1 earnings by 14 yet shares fall 2 as investors eye margin pressures Crit Metals CRMLW Slips 344 Testing 427 Support 20260518 Roku ROKU Stock Today Drops 142 Key Support at 11786 20260515 Entergy ENJ Stock Analysis Falls 075 Watching 1895 20260519 First Foundation FFWM Q4 2025 Earnings Miss EPS 010 vs 003 Expected Short Sellers Target Fake AI Stocks as Tech Mania Creates Bearish Opportunities Fresh Del FDP Q1 2026 Earnings EPS 063 Beats Estimates 10x Genomics TXG Q1 2026 Results Exceed Forecasts Key Drivers Inside Oxford Lane Capital Corp Reports Fiscal Year 2026 Fourth Quarter Results IBM Q1 2026 Earnings EPS Surpasses Estimates as Company Continues Strategic Transformation On Holding AG ONON Q1 2026 Earnings Strong EPS Beat Drives Positive Sentiment SBLK Q1 2026 Earnings Strong Beat on EPS as Dry Bulk Market Improves Dell Technologies Q1 2026 Earnings EPS Surges Past Estimates with 811 Surprise CNM Q1 2026 Earnings EPS Surpasses Estimates by Nearly 23 Fueled by Strong Demand in Water Infrastructure Nova Minerals NVA Weakness Tests Key Support After 34 Decline Flutter Entertainment FLUT Gains 2 as Shares Approach Key Resistance Level Humana HUM Edges Higher as Shares Test Key Resistance Levels Filana Therapeutics FLNA Gains 638 as Biotech Momentum Builds